Tan, W. C., Jain, A., Barbier, S., Ng, Q. S., Kanesvaran, R., Ang, M.-K., … Tan, D.-W. (2014). Relationship between tumor response with outcomes in EGFR mutation positive (M+) non-small cell lung cancer (NSCLC) treated with tyrosine-kinase inhibitors (TKI). In Journal of Clinical Oncology (Vol. 32, pp. e19101–e19101). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.e19101

Tan, Wei Chong, Amit Jain, Sylvaine Barbier, Quan Sing Ng, Ravindran Kanesvaran, Mei-Kim Ang, Angela Takano, et al. “Relationship between tumor response with outcomes in EGFR mutation positive (M+) non-small cell lung cancer (NSCLC) treated with tyrosine-kinase inhibitors (TKI).” In Journal of Clinical Oncology, 32:e19101–e19101. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.e19101.

Tan WC, Jain A, Barbier S, Ng QS, Kanesvaran R, Ang M-K, et al. Relationship between tumor response with outcomes in EGFR mutation positive (M+) non-small cell lung cancer (NSCLC) treated with tyrosine-kinase inhibitors (TKI). In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. e19101–e19101.

Tan, Wei Chong, et al. “Relationship between tumor response with outcomes in EGFR mutation positive (M+) non-small cell lung cancer (NSCLC) treated with tyrosine-kinase inhibitors (TKI).” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. e19101–e19101. Crossref, doi:10.1200/jco.2014.32.15_suppl.e19101.

Tan WC, Jain A, Barbier S, Ng QS, Kanesvaran R, Ang M-K, Takano A, Lim KH, Tan WM, Toh CK, Chakraborty B, Lim W-T, Tan EH, Tan DS-W. Relationship between tumor response with outcomes in EGFR mutation positive (M+) non-small cell lung cancer (NSCLC) treated with tyrosine-kinase inhibitors (TKI). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. e19101–e19101.